 |
|
|
|
|
|
|
|
|
|
|
 |
|
|||||||||
 |
 |
 |
 |
 |
 |
 |
 |
|
||
 |
 |
 |
|
|||||||
 |
|
|||||||||
 |
|
|||||||||
Alert Number 81
Date: February 25, 2024
The February 24, 2024 issue of the prestigious New England Journal of Medicine has an article in it that is of pivotal importance to all of us battling CLL. More than half dozen of our members bought and sent me full text copy of this article. Just goes to show we are a wide awake patient community.
In the last couple of years several experts have been sounding the call for therapy decisions made on the basis of modern prognostic indicators, not an automatic W&W for all early Rai stage patients. In this article Dr. Kanti Rai, the inventor of the "Rai Staging" system, writes that with the passing of time and a better understanding of the disease, the staging system that bears his name should be replaced by modern prognostic methods. Ladies and gentlemen, the age of prognostics-based therapy is officially here.
Truly, this is a must-read article for all CLL patients and professionals. For those of us who are challenged by medical jargon, I have tried to organize and highlight the important bits in my review, Dawn of a New Era, has just been published.
Be well.
Chaya
_____
NOTICE: This page from the Topics Alert archive was originally emailed to subscribers of Topics Alert, a free service of CLL Topics Inc. If you are not a subscriber and you wish to receive email Alerts, please register at the Topics Alert subscription page. The content of this page is intended for information only and it is NOT meant to be medical advice. Please be sure to consult and follow the advice of your doctors on all medical matters.
———
Disclaimer: The content of this website is intended for information only and is NOT meant to be medical advice. Please be sure to consult and follow the advice of your doctors on all medical matters.
Copyright Notice:
Copyright © 2024-2007 CLL Topics, Inc. All Rights Reserved.
All materials contained on this site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of CLL Topics, Inc. You may not alter or remove any trademark, copyright or other notice from copies of the content.
However, you may download and print material from CLLTopics.org exclusively for your personal, noncommercial use.
———
